Ippei Sakamaki

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Standardized treatments for indolent B cell lymphoma primarily consisting of follicular lymphoma (FL) and for mantle cell lymphoma (MCL) have yet to be established. Here the Hokuriku Hematology Oncology Study Group conducted a multicenter prospective study to investigate the efficacy and safety of a combination regimen of rituximab, cladribine,(More)
  • 1